Pharma Industry Overview Indian pharma is a ~INR 2.1 trillion (~US$28 billion) opportunity and is projected to become ~INR 3.2 trillion (~US$43 billion) by 2025 (growing at ~9% CAGR), led by growth in the chronic segment, non-metro markets and organized channel. Healthcare spend in India grew at a healthy ~13% CAGR from 2015 to 2019, … Continue reading API Holdings – PharmEasy Listing Price Justified?